Buy Like Buffett
Watchlist

Flagship explainer

How MYRIAD GENETICS, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$825M · 100%Cost of revenue$248M · 30%Gross profit$577M · 70%Operating income−$387M · −47%Income before tax−$395M · −48%Income tax−$29.2M · −4%Net income−$366M · −44%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$825M100%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
Cost of revenue$248M30%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
$577M70%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
−$387M−47%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
Income before tax−$395M−48%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
Income tax−$29.2M−4%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
−$366M−44%
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0000899923-26-000018 · filed Feb 24, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full MYRIAD GENETICS, INC. analysis at Buy Like Buffett